Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gronchi

Showing results (281-290 of 486) with videos related to

Pageof 49
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
Molecular Cancer Therapeutics|February 5, 2009
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumorsClaudia Forni, Mario Minuzzo, Emanuela Virdis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2010
Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumorsRoberta Frapolli, Elena Tamborini, Emanuela Virdis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in MilanAndrea Ferrari, Michela Casanova, Paola Collini, et al.
Cancer|May 13, 2022
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysisSilvia Stacchiotti, Winette T A Van der Graaf, Roberta G Sanfilippo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 26, 2024
Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimizationMassimiliano Gennaro, Luigi Mariani, Elena Palassini, et al.
Tumori|January 6, 2024
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approachAmelia Barcellini, Chiara Cassani, Ester Orlandi, et al.
Cancer Medicine|July 17, 2023
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centersPaola Zagami, Alessandro Comandone, Marco Fiore, et al.
Cancer|July 15, 2023
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wallMaria Danieli, Francesco Barretta, Stefano Radaelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumorsFrancesca C Miselli, Paola Casieri, Tiziana Negri, et al.
Pageof 49

Showing results (281-290 of 486) with videos related to

Sort By:
Pageof 49
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
Molecular Cancer Therapeutics|February 5, 2009
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumorsClaudia Forni, Mario Minuzzo, Emanuela Virdis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2010
Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumorsRoberta Frapolli, Elena Tamborini, Emanuela Virdis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in MilanAndrea Ferrari, Michela Casanova, Paola Collini, et al.
Cancer|May 13, 2022
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysisSilvia Stacchiotti, Winette T A Van der Graaf, Roberta G Sanfilippo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 26, 2024
Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimizationMassimiliano Gennaro, Luigi Mariani, Elena Palassini, et al.
Tumori|January 6, 2024
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approachAmelia Barcellini, Chiara Cassani, Ester Orlandi, et al.
Cancer Medicine|July 17, 2023
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centersPaola Zagami, Alessandro Comandone, Marco Fiore, et al.
Cancer|July 15, 2023
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wallMaria Danieli, Francesco Barretta, Stefano Radaelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumorsFrancesca C Miselli, Paola Casieri, Tiziana Negri, et al.
Pageof 49